Blanch L, Weber B, Guo X-H, Scott HS, Hopwood JJ. Molecular defects in Sanfilippo syndrome type A. (1997) Human Molecular Genetics 6: 787-791.
Bond CA, Clements PR, Ashby SJ, Collyer CA, Harrop SJ, Hopwood JJ and Guss JM. Structure of a human lysosomal sulfatase. (1997) Structure 5: 277-289.
Paton BC, Heron SE, Nelson PV, Morris CP, Poulos A. Absence of mutations raises doubts about the role of the 70-kD peroxisomal membrane protein in Zellweger syndrome. (1997). American Journal of Human Genetics 60: 1535-1539
Byers S, Nuttall JC, Crawley AC, Hopwood JJ, Smith K, Fazzalari NL. The effect of enzyme replacement therapy on bone formation in an animal model of mucopolysaccharidosis type VI. (1997). Bone 21: 425-431.
Crawley AC, Niedzielski KH, Isaac EL, Davey RCA, Byers S and Hopwood JJ. Enzyme replacement therapy from birth in a feline model of mucopolysaccharidosis type VI. (1997) Journal of Clinical Investigation 99: 651-662
Harzer K, Paton BC, Christomanou H, Chatelut M, Levade T, Hiraiwa M, O’Brien JS. Saposins (sap) A and C activate the degradation of galactosylceramide in living cells. (1997) FEBS Letters 417: 270-274
Meikle PJ, Brooks DA, Ravenscroft EM, Yan M, Williams RE, Jaunzems AE, Chataway TK, Karageorgos LE, Davey RC, Boulter CD, Carlsson SR, Hopwood JJ. Diagnosis of lysosomal storage disorders: evaluation of lysosome-associated membrane protein LAMP-1 as a diagnostic marker. (1997). Clinical Chemistry 43: 1325-1335.
Weber B, Guo X-H, Wraith JE, Cooper A, Kleijer WJ, Bunge S, Hopwood JJ. Novel mutations in Sanfilippo A syndrome: implications for enzyme function. (1997) Human Molecular Genetics 6: 1573-1579.
Crawley AC, Yogalingam G, Muller VJ, Hopwood JJ. Two mutations within a feline mucopolysaccharidosis type VI colony cause three different clinical phenotypes. (1998) Journal of Clinical Investigation 101: 109-119.
Jones MZ, Alroy J, Boyer PJ, Cavanagh KT, Johnson K, Gage D, Vorro J, Render JA, Common RS, Leedle RA, Lowrie C, Sharp P, Liour S-S, Levene B, Hoard H, Lucas R, Hopwood JJ. Caprine mucopolysaccharidosis IIID: clinical, biochemical morphological and immunohistochemical characteristics. (1998) Journal of Neuropathology and Experimental Neurology 57: 148-157.
Bielicki J, Crawley AC, Davey RCA, Varnai JC, Hopwood JJ. Advantages of using same species enzyme replacement therapy in a feline model of mucopolysaccharidosis type VI. (1999) Journal of Biological Chemistry 274: 36335-36343.
Bradford TM, Gething M-J, Davey R, Hopwood JJ, Brooks DA. Processing of normal lysosomal and mutant N-acetylgalactosamine 4-sulphatase: BiP (immunoglobulin heavy-chain binding protein) may interact with critical protein contact sites. Biochemical Journal 341, 193-201
Maxwell MA, Nelson PV, Chin SJ, McIntyre NE, Paton BC, Carey WF, Crane DI. A common PEX1 frameshift mutation in patients with disorders of peroxisome beiogenesis correlates with the severe Zellweger syndrome phenotype. (1999). Human Genetics 105: 38-44.
Meikle PJ, Hopwood JJ, Clague AE, Carey WF. Prevalence of lysosomal storage disorders. (1999). Journal of the American Medical Association 281: 249-254.
Perkins KJ, Byers S, Yogalingam G, Weber B, Hopwood JJ. Characterisation and expression of wild type and mutant recombinant human sulfamidase: implications for Sanfilippo (MPS IIIA) syndrome. (1999) Journal of Biological Chemistry 574: 37193-37199.
Poplawski NK, Ranieri E, Harrison JR, Fletcher JM. Multiple acyl-coenzyme A dehydrogenase deficiency: diagnosis by acyl-carnitine analysis of a 12-year old newborn screening card. (1999) Journal of Paediatrics 134: 764-766.
Byers S, Moore AJ, Byard RW, Fazzalari NL. Quantitative histomorphometric analysis of the human growth plate from birth to adolescence. (2000) Bone 27: 495-501.
Cheffins T, Chan A, Haan EA, Ryall RG, Keane RJ, Byron-Scott R, Scott H, Gjerde EM, Nguyen A-M, Ford JH, Sykes S. The impact of maternal serum screening on the birth prevalence of Down’s syndrome and the use of amniocentesis and chorionic villus sampling in South Australia. British Journal of Obstetrics and Gynaecology (2000) 107: 1453-1459..
Hopwood JJ, Ballabio A. Multiple sulfatase deficiency and nature of the sulfatase family. (2000) In: The Metabolic and Molecular Bases of Inherited Disease. Scriver CR, Beaudet AL, Sly WS, Valle D (Eds.), 8th Edition.. McGraw-Hill, New York, pp. 3725-3732.
Muntau AC, Mayerhofer PU, Paton BC, Kammerer S, Roscher AA. Defective peroxisome membrane synthesis due to mutations in human PEX3 causes Zellweger syndrome, complementation group G. (2000) American Journal of Human Genetics 67: 967-975.
Umapathysivam K, Whittle AM, Ranieri E, Bindloss CA, Ravenscroft EM, Hopwood JJ, Meikle PJ. Acid _-glucosidase: evaluation as a marker for Pompe disease and other lysosomal storage disorders. (2000) Clinical Chemistry 46: 1318-1325.
Wakefield M, Banham D, McCaul K, Martin J, Ruffin R, Badcock NR, Roberts L. Effects of feedback of urinary cotinine and brief tailored advice on home smoking restrictions among low income parents of children with asthma: randomised control trial. (2000) American Journal of Preventative Medicine 19: 297-300
Johnson DW, ten Brink HJ, Schuit RC, Jakobs C. Rapid and quantitative analysis of unconjugated C27 bile acids in plasma and blood samples by tandem mass spectrometry. (2001) Journal of Lipid Research 42: 9-16.
Keeling KM, Brooks DA, Hopwood JJ, Li P, Thompson JL, Bedwell DM. Gentamicin-mediated suppression of Hurler syndrome stop mutations restores a low level of a-L-iduronidase activity and reduces lysosomal glycosaminoglycan accumulation. (2001) Human Molecular Genetics 10: 291-299.
